1Peleg AY,Hooper DC.Hospital-acquired infections due to gram-negative bacteria[J].N Engl J Med,2010,362(19):1804-1813.
2Gaynes R,Edwards JR.Overview of nosocomial infections caused by gram-negative bacilli[J].Clin Infect Dis,2005,41 (6):848-854.
3Hidron AI,Edwards JR,Patel J,et al.NHSN annual update:antimicrobial-resistant pathogens associated with healthcare-associated infections:annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention,2006-2007[J].Infect Control Hosp Epidemiol,2008,29(11):996-1011.
4Valencia R,Arroyo LA,Conde M,et al.Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital[J].Infect Control Hosp Epidemiol,2009,30(3):257-263.
5Soo HGW,Wen YE,Nguyen TV,et al.Impact of clinical guidelines in the management of severe hospital-acquired pneumonia[J].Chest,2005,128(4):2778-2787.
6Nachtigall I,Tamarkin A,Tafelski S,et al.Impact of adherence to standard operating procedures for pneumonia on outcome of intensive care unit patients[J].Crit Care Med,2009,37(1):159-166.
7Nseir S,Grailles G,Soury-Lavergne A,et al.Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission[J].Clin Microbiol Infect,2009.[Epub ahead of print].
8Fujitani S,Yu VL.Diagnosis of ventilator-associated pneumonia:focus on nonbronchoscopic techniques (nonbronchoscopic bronchoalveolar lavage,including mini-BAL,blinded protected specimen brush,and blinded bronchial sampling) and endotracheal aspirates[J].J Intensive Care Med,2006,21(1):17-21.
9Falagas ME,Rafailidis PI.Attributable mortality of Acinetobacter baumannii:no longer a controversial issue[J].Crit Care,2007,11(3):134.
10Urban C,Go E,Mariano N,et al.Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus[J].J Infect Dis,1993,167(2):448-451.
